SCHEMBL24310049

SCHEMBL24310049

CCOc1ccccc1-c1nc(NSc2cnn(C)c2)nc(Oc2cccc(N3CCN(C)CC3)c2Cl)c1CC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PAK1 Q13153 2/20 0.36
▸ DRD2 P14416 4/20 0.34
▸ DRD4 P21917 2/20 0.34
▸ DRD3 P35462 2/20 0.34
▸ HTR1A P08908 2/20 0.34
▸ HTR2A P28223 2/20 0.34
▸ HTR2C P28335 1/20 0.34
▸ TNK2 Q07912 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ BRD4 O60885 2/20 0.33
▸ BRPF1 P55201 1/20 0.33
▸ BRD9 Q9H8M2 1/20 0.33
▸ DRD1 P21728 1/20 0.32
▸ EGFR P00533 1/20 0.32
▸ SIGMAR1 Q99720 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ SCN5A Q14524 1/20 0.32
▸ MAP4K1 Q92918 1/20 0.32
▸ HTR7 P34969 1/20 0.32
▸ HTR6 P50406 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310513 0.93 MEN1 (0.33) PAK1DRD2DRD4DRD3HTR1A
SCHEMBL24310089 0.92 DRD2 (0.35) PAK1DRD2DRD4DRD3HTR1A
SCHEMBL24309536 0.91 BRPF1 (0.34) PAK1DRD2DRD4DRD3HTR1A
SCHEMBL24309479 0.91 HTR1A (0.33) PAK1DRD2DRD4DRD3HTR1A
SCHEMBL24310065 0.90 DRD2 (0.37) PAK1DRD2DRD4DRD3HTR1A
SCHEMBL24310772 0.89 HTR1A (0.33) DRD2DRD4DRD3HTR1AHTR2A
SCHEMBL24309527 0.87 DRD2 (0.39) DRD2DRD4DRD3HTR1AHTR2A
SCHEMBL24309430 0.85 PAK1 (0.32) PAK1DRD2DRD4DRD3HTR1A
SCHEMBL24310048 0.85 HTR1A (0.38) PAK1DRD2DRD4DRD3HTR1A
SCHEMBL29566746 0.85 HTR1A (0.38) PAK1DRD2DRD4DRD3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback